Ascent Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $250K | Buy |
+3,199
| New | +$250K | 0.01% | 628 |
|
|
2024
Q3 | – | Sell |
-2,719
| Closed | -$251K | – | 531 |
|
|
2024
Q2 | $251K | Sell |
2,719
-1,364
| -33% | -$126K | 0.02% | 455 |
|
|
2024
Q1 | $390K | Sell |
4,083
-1,745
| -30% | -$167K | 0.03% | 390 |
|
|
2023
Q4 | $508K | Sell |
5,828
-252
| -4% | -$22K | 0.05% | 344 |
|
|
2023
Q3 | $393K | Sell |
6,080
-10,884
| -64% | -$704K | 0.04% | 350 |
|
|
2023
Q2 | $1.33M | Sell |
16,964
-5,859
| -26% | -$460K | 0.15% | 195 |
|
|
2023
Q1 | $1.89M | Sell |
22,823
-433
| -2% | -$35.8K | 0.2% | 151 |
|
|
2022
Q4 | $1.74M | Buy |
23,256
+356
| +2% | +$26.6K | 0.2% | 151 |
|
|
2022
Q3 | $1.66M | Buy |
22,900
+394
| +2% | +$28.5K | 0.2% | 146 |
|
|
2022
Q2 | $2.26M | Sell |
22,506
-35
| -0.2% | -$3.52K | 0.27% | 111 |
|
|
2022
Q1 | $2.65M | Sell |
22,541
-6,697
| -23% | -$789K | 0.31% | 108 |
|
|
2021
Q4 | $3.29M | Buy |
+29,238
| New | +$3.29M | 0.42% | 70 |
|